The DOI matches its Crossref record; 464 of the 464 references it cites were found in a registry or an index.
Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets
Open accessAbstract
The onset of heart failure is typically preceded by cardiac hypertrophy, a response of the heart to increased workload, a cardiac insult such as a heart attack or genetic mutation. Cardiac hypertrophy is usually characterized by an increase in cardiomyocyte size and thickening of ventricular walls. Initially, such growth is an adaptive response to maintain cardiac function; however, in settings of sustained stress and as time progresses, these changes become maladaptive and the heart ultimately fails. In this review, we discuss the key features of pathological cardiac hypertrophy and the numerous mediators that have been found to be involved in the pathogenesis of cardiac hypertrophy affecting gene transcription, calcium handling, protein synthesis, metabolism, autophagy, oxidative stress and inflammation. We also discuss new mediators including signaling proteins, microRNAs, long noncoding RNAs and new findings related to the role of calcineurin and calcium-/calmodulin-dependent protein kinases. We also highlight mediators and processes which contribute to the transition from adaptive cardiac remodeling to maladaptive remodeling and heart failure. Treatment strategies for heart failure commonly include diuretics, angiotensin converting enzyme inhibitors, angiotensin II receptor blockers and β-blockers; however, mortality rates remain high. Here, we discuss new therapeutic approaches (e.g., RNA-based therapies, dietary supplementation, small molecules) either entering clinical trials or in preclinical development. Finally, we address the challenges that remain in translating these discoveries to new and approved therapies for heart failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–400 of 464
Schaper, J., Meiser, E., & Stämmler, G. (1985) · Circulation Research · doi:10.1161/01.res.56.3.377 · Cited by 295
Conditional Dicer Gene Deletion in the Postnatal Myocardium Provokes Spontaneous Cardiac Remodeling
da Costa Martins, P. A., Bourajjaj, M., Gladka, M., Kortland, M., van Oort, R. J., Pinto, Y. M., Molkentin, J. D., & De Windt, L. J. (2008) · Circulation · doi:10.1161/circulationaha.108.769984 · Cited by 293
Bish, L. T., Morine, K., Sleeper, M. M., Sanmiguel, J., Wu, D., Gao, G., Wilson, J. M., & Sweeney, H. L. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.123 · Cited by 292
Catecholamines, Cardiac β-Adrenergic Receptors, and Heart Failure
Lefkowitz, R. J., Rockman, H. A., & Koch, W. J. (2000) · Circulation · doi:10.1161/01.cir.101.14.1634 · Cited by 291 · cited 1×
“Human and mouse studies suggest that acute activation of β/β 1 -AR may initially be adaptive because it increases contractility (Du 1 3 2008; Engelhardt et al. 1999; Lefkowitz et al. 2000; Rockman et al. 2002).”
BackgroundSchwinger, R. H. G., Münch, G., Bölck, B., Karczewski, P., Krause, E.-G., & Erdmann, E. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1998.0897 · Cited by 287
Ounzain, S., Micheletti, R., Beckmann, T., Schroen, B., Alexanian, M., Pezzuto, I., Crippa, S., Nemir, M., Sarre, A., Johnson, R., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu180 · Cited by 281
Yeh, Y.-H., Wakili, R., Qi, X.-Y., Chartier, D., Boknik, P., Kääb, S., Ravens, U., Coutu, P., Dobrev, D., & Nattel, S. (2008) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.107.754788 · Cited by 279
Evidence of oxidative stress in chronic heart failure in humans
McMURRAY, J., CHOPRA, M., ABDULLAH, I., SMITH, W. E., & DARGIE, H. J. (1993) · European Heart Journal · doi:10.1093/eurheartj/14.11.1493 · Cited by 278
Kunisada, K., Negoro, S., Tone, E., Funamoto, M., Osugi, T., Yamada, S., Okabe, M., Kishimoto, T., & Yamauchi-Takihara, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.315 · Cited by 273
Diuretic response in acute heart failure—pathophysiology, evaluation, and therapy
ter Maaten, J. M., Valente, M. A. E., Damman, K., Hillege, H. L., Navis, G., & Voors, A. A. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.215 · Cited by 273
Energy Metabolism in the Normal and Failing Heart: Potential for Therapeutic Interventions
Stanley, W. C., & Chandler, M. P. (2002) · Heart Failure Reviews · doi:10.1023/a:1015320423577 · Cited by 271
Perrino, C. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25397 · Cited by 268
Kehat, I., Davis, J., Tiburcy, M., Accornero, F., Saba-El-Leil, M. K., Maillet, M., York, A. J., Lorenz, J. N., Zimmermann, W. H., Meloche, S., et al. (2011) · Circulation Research · doi:10.1161/circresaha.110.231514 · Cited by 259
Mende, U., Kagen, A., Cohen, A., Aramburu, J., Schoen, F. J., & Neer, E. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13893 · Cited by 258
MicroRNAs as Therapeutic Targets and Biomarkers of Cardiovascular Disease
Olson, E. N. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009008 · Cited by 255
Hsp72 preserves muscle function and slows progression of severe muscular dystrophy
Gehrig, S. M., van der Poel, C., Sayer, T. A., Schertzer, J. D., Henstridge, D. C., Church, J. E., Lamon, S., Russell, A. P., Davies, K. E., Febbraio, M. A., et al. (2012) · Nature · doi:10.1038/nature10980 · Cited by 250
Non-coding RNAs in Cardiac Remodeling and Heart Failure
Kumarswamy, R., & Thum, T. (2013) · Circulation Research · doi:10.1161/circresaha.113.300226 · Cited by 249
Intracellular Protein Aggregation Is a Proximal Trigger of Cardiomyocyte Autophagy
Tannous, P., Zhu, H., Nemchenko, A., Berry, J. M., Johnstone, J. L., Shelton, J. M., Miller, F. J., Rothermel, B. A., & Hill, J. A. (2008) · Circulation · doi:10.1161/circulationaha.107.763870 · Cited by 248
Zhang, C. L., McKinsey, T. A., & Olson, E. N. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7302-7312.2002 · Cited by 246
Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt
Chan, A. Y. M., Dolinsky, V. W., Soltys, C.-L. M., Viollet, B., Baksh, S., Light, P. E., & Dyck, J. R. B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802869200 · Cited by 244 · cited 1×
“Pharmacological activation of AMPK has been shown to inhibit the mTOR pathway and attenuate pressure overload-induced hypertrophy (Chan et al. 2004, 2008; Li et al. 2007).”
BackgroundAn emerging consensus on cardiac regeneration
van Berlo, J. H., & Molkentin, J. D. (2014) · Nature Medicine · doi:10.1038/nm.3764 · Cited by 244
Long Noncoding RNAs Usher In a New Era in the Biology of Enhancers
Ørom, U. A., & Shiekhattar, R. (2013) · Cell · doi:10.1016/j.cell.2013.08.028 · Cited by 243
Takeishi, Y., Ping, P., Bolli, R., Kirkpatrick, D. L., Hoit, B. D., & Walsh, R. A. (2000) · Circulation Research · doi:10.1161/01.res.86.12.1218 · Cited by 239
Ganesan, J., Ramanujam, D., Sassi, Y., Ahles, A., Jentzsch, C., Werfel, S., Leierseder, S., Loyer, X., Giacca, M., Zentilin, L., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000882 · Cited by 239
Munger, M. A., Johnson, B., Amber, I. J., Callahan, K. S., & Gilbert, E. M. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89206-5 · Cited by 237
Raake, P. W. J., Vinge, L. E., Gao, E., Boucher, M., Rengo, G., Chen, X., DeGeorge, B. R., Matkovich, S. J., Houser, S. R., Most, P., et al. (2008) · Circulation Research · doi:10.1161/circresaha.107.168336 · Cited by 236
Takahashi, T., Allen, P. D., & Izumo, S. (1992) · Circulation Research · doi:10.1161/01.res.71.1.9 · Cited by 232
Bowman, J. C., Steinberg, S. F., Jiang, T., Geenen, D. L., Fishman, G. I., & Buttrick, P. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119755 · Cited by 229
Pathak, A., del Monte, F., Zhao, W., Schultz, J.-E., Lorenz, J. N., Bodi, I., Weiser, D., Hahn, H., Carr, A. N., Syed, F., et al. (2005) · Circulation Research · doi:10.1161/01.res.0000161256.85833.fa · Cited by 228
TNFα in myocardial ischemia/reperfusion, remodeling and heart failure
Kleinbongard, P., Schulz, R., & Heusch, G. (2011) · Heart Failure Reviews · doi:10.1007/s10741-010-9180-8 · Cited by 226
Hayakawa, Y., Chandra, M., Miao, W., Shirani, J., Brown, J. H., Dorn, G. W., Armstrong, R. C., & Kitsis, R. N. (2003) · Circulation · doi:10.1161/01.cir.0000101920.72665.58 · Cited by 224
Decompensation of Cardiac Hypertrophy: Cellular Mechanisms and Novel Therapeutic Targets
Diwan, A., & Dorn, G. W. (2007) · Physiology · doi:10.1152/physiol.00033.2006 · Cited by 224
Hajjar, R. J., Zsebo, K., Deckelbaum, L., Thompson, C., Rudy, J., Yaroshinsky, A., Ly, H., Kawase, Y., Wagner, K., Borow, K., et al. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2008.02.005 · Cited by 222
Kenessey, A., & Ojamaa, K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512671200 · Cited by 222
A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy
Lorenz, K., Schmitt, J. P., Schmitteckert, E. M., & Lohse, M. J. (2009) · Nature Medicine · doi:10.1038/nm.1893 · Cited by 220
New drugs cost US$2.6 billion to develop
Mullard, A. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4507 · Cited by 217
Insulin-Like Growth Factor I Receptor Signaling Is Required for Exercise-Induced Cardiac Hypertrophy
Kim, J., Wende, A. R., Sena, S., Theobald, H. A., Soto, J., Sloan, C., Wayment, B. E., Litwin, S. E., Holzenberger, M., LeRoith, D., et al. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0265 · Cited by 215
Myocyte Adrenoceptor Signaling Pathways
Xiang, Y., & Kobilka, B. K. (2003) · Science · doi:10.1126/science.1079206 · Cited by 214
Cardinale, J. P., Sriramula, S., Pariaut, R., Guggilam, A., Mariappan, N., Elks, C. M., & Francis, J. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.154567 · Cited by 213
Suckau, L., Fechner, H., Chemaly, E., Krohn, S., Hadri, L., Kockskämper, J., Westermann, D., Bisping, E., Ly, H., Wang, X., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.783852 · Cited by 212
A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer
Kasinski, A. L., Kelnar, K., Stahlhut, C., Orellana, E., Zhao, J., Shimer, E., Dysart, S., Chen, X., Bader, A. G., & Slack, F. J. (2015) · Oncogene · doi:10.1038/onc.2014.282 · Cited by 210
White, D. C., Hata, J. A., Shah, A. S., Glower, D. D., Lefkowitz, R. J., & Koch, W. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090091197 · Cited by 208
The GSK-3 Family as Therapeutic Target for Myocardial Diseases
Lal, H., Ahmad, F., Woodgett, J., & Force, T. (2015) · Circulation Research · doi:10.1161/circresaha.116.303613 · Cited by 206
O’Connell, T. D., Jensen, B. C., Baker, A. J., & Simpson, P. C. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007203 · Cited by 205
Rengo, G., Lymperopoulos, A., Zincarelli, C., Donniacuo, M., Soltys, S., Rabinowitz, J. E., & Koch, W. J. (2009) · Circulation · doi:10.1161/circulationaha.108.803999 · Cited by 205
Naga Prasad, S. V., Esposito, G., Mao, L., Koch, W. J., & Rockman, H. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.7.4693 · Cited by 204
Gidlöf, O., Smith, J. G., Miyazu, K., Gilje, P., Spencer, A., Blomquist, S., & Erlinge, D. (2013) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-13-12 · Cited by 203
Braz, J. C., Bueno, O. F., De Windt, L. J., & Molkentin, J. D. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200108062 · Cited by 199
Autophagy in Load-Induced Heart Disease
Rothermel, B. A., & Hill, J. A. (2008) · Circulation Research · doi:10.1161/circresaha.108.186551 · Cited by 199
Class IA Phosphoinositide 3-Kinase Regulates Heart Size and Physiological Cardiac Hypertrophy
Luo, J., McMullen, J. R., Sobkiw, C. L., Zhang, L., Dorfman, A. L., Sherwood, M. C., Logsdon, M. N., Horner, J. W., DePinho, R. A., Izumo, S., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9491-9502.2005 · Cited by 198
Self-citationSignaling chromatin to make muscle
McKinsey, T. A., Zhang, C. L., & Olson, E. N. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00389-7 · Cited by 198
Liao, R., Nascimben, L., Friedrich, J., Gwathmey, J. K., & Ingwall, J. S. (1996) · Circulation Research · doi:10.1161/01.res.78.5.893 · Cited by 197
Kiss, E., Ball, N. A., Kranias, E. G., & Walsh, R. A. (1995) · Circulation Research · doi:10.1161/01.res.77.4.759 · Cited by 195
Exercise, antioxidants, and HSP72: protection against myocardial ischemia/reperfusion
Hamilton, K. L., Staib, J. L., Phillips, T., Hess, A., Lennon, S. L., & Powers, S. K. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01431-4 · Cited by 194
Shah, A. S., White, D. C., Emani, S., Kypson, A. P., Lilly, R. E., Wilson, K., Glower, D. D., Lefkowitz, R. J., & Koch, W. J. (2001) · Circulation · doi:10.1161/01.cir.103.9.1311 · Cited by 194
Protein kinase C in heart failure: a therapeutic target?
Palaniyandi, S. S., Sun, L., Ferreira, J. C. B., & Mochly-Rosen, D. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvp001 · Cited by 193
Sorokina, N., O’Donnell, J. M., McKinney, R. D., Pound, K. M., Woldegiorgis, G., LaNoue, K. F., Ballal, K., Taegtmeyer, H., Buttrick, P. M., & Lewandowski, E. D. (2007) · Circulation · doi:10.1161/circulationaha.106.668665 · Cited by 193
Dobrev, D., & Wehrens, X. H. T. (2014) · Circulation Research · doi:10.1161/circresaha.114.300568 · Cited by 192
HDAC4 controls histone methylation in response to elevated cardiac load
Hohl, M., Wagner, M., Reil, J.-C., Müller, S.-A., Tauchnitz, M., Zimmer, A. M., Lehmann, L. H., Thiel, G., Böhm, M., Backs, J., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci61084 · Cited by 192
Virtanen, J. K., Mursu, J., Voutilainen, S., & Tuomainen, T.-P. (2009) · Circulation · doi:10.1161/circulationaha.109.852657 · Cited by 189
Song, M., Chen, Y., Gong, G., Murphy, E., Rabinovitch, P. S., & Dorn, G. W. (2014) · Circulation Research · doi:10.1161/circresaha.115.304384 · Cited by 188
Pretorius, L., Du, X.-J., Woodcock, E. A., Kiriazis, H., Lin, R. C. Y., Marasco, S., Medcalf, R. L., Ming, Z., Head, G. A., Tan, J. W., et al. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.090126 · Cited by 187
Self-citationDorn, G. W., & Kitsis, R. N. (2015) · Circulation Research · doi:10.1161/circresaha.116.303554 · Cited by 187
Zhang, P., Hu, X., Xu, X., Fassett, J., Zhu, G., Viollet, B., Xu, W., Wiczer, B., Bernlohr, D. A., Bache, R. J., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.114702 · Cited by 187
Giannetta, E., Isidori, A. M., Galea, N., Carbone, I., Mandosi, E., Vizza, C. D., Naro, F., Morano, S., Fedele, F., & Lenzi, A. (2012) · Circulation · doi:10.1161/circulationaha.111.063412 · Cited by 185
Byrne, M. J., Power, J. M., Preovolos, A., Mariani, J. A., Hajjar, R. J., & Kaye, D. M. (2008) · Gene Therapy · doi:10.1038/gt.2008.120 · Cited by 184
Swimming Training in Rats Increases Cardiac MicroRNA-126 Expression and Angiogenesis
DA SILVA, N. D., FERNANDES, T., SOCI, U. P. R., MONTEIRO, A. W. A., PHILLIPS, M. I., & DE OLIVEIRA, E. M. (2012) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31824e8a36 · Cited by 179
Kreusser, M. M., Lehmann, L. H., Keranov, S., Hoting, M.-O., Oehl, U., Kohlhaas, M., Reil, J.-C., Neumann, K., Schneider, M. D., Hill, J. A., et al. (2014) · Circulation · doi:10.1161/circulationaha.114.006185 · Cited by 177
Selective repression of MEF2 activity by PKA-dependent proteolysis of HDAC4
Backs, J., Worst, B. C., Lehmann, L., Patrick, D. M., Jebessa, Z. H., Kreußer, M. M., Sun, Q., Chen, L., Heft, C., Katus, H. A., et al. (2011) · The Journal of Cell Biology · doi:10.1083/jcb.201105063 · Cited by 174
Noncoding RNAs and myocardial fibrosis
Thum, T. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.125 · Cited by 173
Ashrafian, H., Horowitz, J. D., & Frenneaux, M. P. (2007) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2007.00006.x · Cited by 173
CaMKII oxidative activation and the pathogenesis of cardiac disease
Luczak, E. D., & Anderson, M. E. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.02.004 · Cited by 172
Williams, S. M., Golden-Mason, L., Ferguson, B. S., Schuetze, K. B., Cavasin, M. A., Demos-Davies, K., Yeager, M. E., Stenmark, K. R., & McKinsey, T. A. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.12.013 · Cited by 171
Gut microbiota metabolism of l-carnitine and cardiovascular risk
Ussher, J. R., Lopaschuk, G. D., & Arduini, A. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.10.013 · Cited by 170
Lin, R. C. Y., Weeks, K. L., Gao, X.-M., Williams, R. B. H., Bernardo, B. C., Kiriazis, H., Matthews, V. B., Woodcock, E. A., Bouwman, R. D., Mollica, J. P., et al. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.201988 · Cited by 170
Self-citationSystemic Delivery of a miR34a Mimic as a Potential Therapeutic for Liver Cancer
Daige, C. L., Wiggins, J. F., Priddy, L., Nelligan-Davis, T., Zhao, J., & Brown, D. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0209 · Cited by 168
Exercise training in swine promotes growth of arteriolar bed and capillary angiogenesis in heart
White, F. C., Bloor, C. M., McKirnan, M. D., & Carroll, S. M. (1998) · Journal of Applied Physiology · doi:10.1152/jappl.1998.85.3.1160 · Cited by 168
Raake, P. W. J., Schlegel, P., Ksienzyk, J., Reinkober, J., Barthelmes, J., Schinkel, S., Pleger, S., Mier, W., Haberkorn, U., Koch, W. J., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehr447 · Cited by 165
Nagayama, T., Hsu, S., Zhang, M., Koitabashi, N., Bedja, D., Gabrielson, K. L., Takimoto, E., & Kass, D. A. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.069 · Cited by 164
Renin-Angiotensin System, Hypertrophy and Gene Expression in Cardiac Myocytes
Lijnen, P., & Petrov, V. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1999.0934 · Cited by 164
Chen, J., Shearer, G. C., Chen, Q., Healy, C. L., Beyer, A. J., Nareddy, V. B., Gerdes, A. M., Harris, W. S., O'Connell, T. D., & Wang, D. (2011) · Circulation · doi:10.1161/circulationaha.110.971853 · Cited by 163
Banke, N. H., Wende, A. R., Leone, T. C., O'Donnell, J. M., Abel, E. D., Kelly, D. P., & Lewandowski, E. D. (2010) · Circulation Research · doi:10.1161/circresaha.110.221713 · Cited by 159
Phosphoinositide 3-Kinase γ–Deficient Mice Are Protected From Isoproterenol-Induced Heart Failure
Oudit, G. Y., Crackower, M. A., Eriksson, U., Sarao, R., Kozieradzki, I., Sasaki, T., Irie-Sasaki, J., Gidrewicz, D., Rybin, V. O., Wada, T., et al. (2003) · Circulation · doi:10.1161/01.cir.0000091403.62293.2b · Cited by 159
Weeks, K. L., Gao, X., Du, X., Boey, E. J. H., Matsumoto, A., Bernardo, B. C., Kiriazis, H., Cemerlang, N., Tan, J. W., Tham, Y. K., et al. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.966622 · Cited by 159
Self-citationGreenberg, B., Yaroshinsky, A., Zsebo, K. M., Butler, J., Felker, G. M., Voors, A. A., Rudy, J. J., Wagner, K., & Hajjar, R. J. (2014) · JACC: Heart Failure · doi:10.1016/j.jchf.2013.09.008 · Cited by 158
Physiological and pathological cardiac hypertrophy induce different molecular phenotypes in the rat
Iemitsu, M., Miyauchi, T., Maeda, S., Sakai, S., Kobayashi, T., Fujii, N., Miyazaki, H., Matsuda, M., & Yamaguchi, I. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.281.6.r2029 · Cited by 157
Calvani, M., Reda, E., & Arrigoni-Martelli, E. (2000) · Basic Research in Cardiology · doi:10.1007/s003950050167 · Cited by 155
Remodeling of Calcium Handling in Human Heart Failure
Lou, Q., Janardhan, A. H., & Efimov, I. R. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-2888-2_52 · Cited by 153
Abnormal cardiac and skeletal muscle mitochondrial function in pacing-induced cardiac failure
Marín-García, J., Goldenthal, M. J., & Moe, G. W. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00368-6 · Cited by 153
Nuclear apoptotic changes: An overview
Martelli, A. M., Zweyer, M., Ochs, R., Tazzari, P. L., Tabellini, G., Narducci, P., & Bortul, R. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1186 · Cited by 148
Radioisotopic determination of l-carnitine content in foods commonly eaten in Western countries
Demarquoy, J., Georges, B., Rigault, C., Royer, M.-C., Clairet, A., Soty, M., Lekounoungou, S., & Borgne, F. L. (2003) · Food Chemistry · doi:10.1016/j.foodchem.2003.09.023 · Cited by 148
Atrogin-1 deficiency promotes cardiomyopathy and premature death via impaired autophagy
Zaglia, T., Milan, G., Ruhs, A., Franzoso, M., Bertaggia, E., Pianca, N., Carpi, A., Carullo, P., Pesce, P., Sacerdoti, D., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci66339 · Cited by 147
Oleate prevents palmitate-induced cytotoxic stress in cardiac myocytes
Miller, T. A., LeBrasseur, N. K., Cote, G. M., Trucillo, M. P., Pimentel, D. R., Ido, Y., Ruderman, N. B., & Sawyer, D. B. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.088 · Cited by 146
Nishino, Y. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.10.022 · Cited by 146
The structure and function of cardiac t-tubules in health and disease
Ibrahim, M., Gorelik, J., Yacoub, M. H., & Terracciano, C. M. (2011) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2011.0624 · Cited by 145
O'Neill, B. T., Kim, J., Wende, A. R., Theobald, H. A., Tuinei, J., Buchanan, J., Guo, A., Zaha, V. G., Davis, D. K., Schell, J. C., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.09.001 · Cited by 143
Nienaber, J. J., Tachibana, H., Prasad, S. V. N., Esposito, G., Wu, D., Mao, L., & Rockman, H. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18213 · Cited by 142
Antifibrotic activity of an inhibitor of histone deacetylases in DOCA‐salt hypertensive rats
Iyer, A., Fenning, A. S., Lim, J., Le, G. T., Reid, R. C., Halili, M. A., Fairlie, D. P., & Brown, L. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00637.x · Cited by 139
Quantitative Control of Adaptive Cardiac Hypertrophy by Acetyltransferase p300
Wei, J. Q., Shehadeh, L. A., Mitrani, J. M., Pessanha, M. G., Slepak, T. I., Webster, K. A., & Bishopric, N. H. (2008) · Circulation · doi:10.1161/circulationaha.107.760488 · Cited by 138
IRF8 suppresses pathological cardiac remodelling by inhibiting calcineurin signalling
Jiang, D., Xiang, W., Zhang, X.-F., Liu, Y., Zhang, Y., Chen, K., Gao, L., Zhou, H., Zhu, X., Liu, P. P., et al. (2014) · Nature Communications · doi:10.1038/ncomms4303 · Cited by 137
Brinks, H., Boucher, M., Gao, E., Chuprun, J. K., Pesant, S., Raake, P. W. J., Huang, Z. M., Wang, X., Qiu, G., Gumpert, A. M., et al. (2010) · Circulation Research · doi:10.1161/circresaha.110.221010 · Cited by 136
Calcineurin and hypertrophic heart disease: novel insights and remaining questions
Bueno, O. F., van Rooij, E., Molkentin, J. D., Doevendans, P. A., & Windt, L. J. D. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00493-x · Cited by 134
Compensated cardiac hypertrophy is characterised by a decline in palmitate oxidation
Akki, A. S., Smith, K., & Seymour, A. L. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9711-y · Cited by 132
Trans fatty acids and cardiovascular disease—epidemiological data
Willett, W. C. (2006) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2006.04.002 · Cited by 132
Failure to Maintain a Low ADP Concentration Impairs Diastolic Function in Hypertrophied Rat Hearts
Tian, R., Nascimben, L., Ingwall, J. S., & Lorell, B. H. (1997) · Circulation · doi:10.1161/01.cir.96.4.1313 · Cited by 132
Kim, Y. K., Suárez, J., Hu, Y., McDonough, P. M., Boer, C., Dix, D. J., & DILLMANN, W. H. (2006) · Circulation · doi:10.1161/circulationaha.105.598409 · Cited by 128
Broderick, T. L., Quinney, H. A., Barker, C. C., & Lopaschuk, G. D. (1993) · Circulation · doi:10.1161/01.cir.87.3.972 · Cited by 128
Protein Kinase Cα Negatively Regulates Systolic and Diastolic Function in Pathological Hypertrophy
Hahn, H. S., Marreez, Y., Odley, A. M., Sterbling, A., Yussman, M. G., Hilty, K. C., Bódi, I., Liggett, S. B., Schwartz, A., & Dorn, G. W. (2003) · Circulation Research · doi:10.1161/01.res.0000105087.79373.17 · Cited by 128
Baumgarten, G., Knuefermann, P., Kalra, D. K., Gao, F., Taffet, G. E., Michael, L., Blackshear, P. J., Carballo, E., Sivasubramanian, N., & Mann, D. L. (2002) · Circulation · doi:10.1161/01.cir.0000015608.37608.18 · Cited by 127
Kaye, D. M., Preovolos, A., Marshall, T., Byrne, M., Hoshijima, M., Hajjar, R., Mariani, J. A., Pepe, S., Chien, K. R., & Power, J. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.03.047 · Cited by 125
Piccini, J. P., Whellan, D. J., Berridge, B. R., Finkle, J. K., Pettit, S. D., Stockbridge, N., Valentin, J., Vargas, H. M., & Krucoff, M. W. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.06.007 · Cited by 125
Maï, W., Janier, M. F., Allioli, N., Quignodon, L., Chuzel, T., Flamant, F., & Samarut, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401843101 · Cited by 125
Li, H., Yin, R., Chen, D., Liu, D., Wang, D., Yang, Q., & Dong, Y. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21197 · Cited by 124
Chylomicron- and VLDL-derived Lipids Enter the Heart through Different Pathways
Bharadwaj, K. G., Hiyama, Y., Hu, Y., Huggins, L. A., Ramakrishnan, R., Abumrad, N. A., Shulman, G. I., Blaner, W. S., & Goldberg, I. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.174458 · Cited by 123
Cardiac Growth Factors in Human Hypertrophy
Serneri, G. G. N., Modesti, P. A., Boddi, M., Cecioni, I., Paniccia, R., Coppo, M., Galanti, G., Simonetti, I., Vanni, S., Papa, L., et al. (1999) · Circulation Research · doi:10.1161/01.res.85.1.57 · Cited by 123
Small Heat-Shock Protein Hsp20 Phosphorylation Inhibits β-Agonist-Induced Cardiac Apoptosis
Fan, G., Chu, G., Mitton, B. A., Song, Q., Yuan, Q., & Kranias, E. G. (2004) · Circulation Research · doi:10.1161/01.res.0000129179.66631.00 · Cited by 121
SUMO-1 Gene Transfer Improves Cardiac Function in a Large-Animal Model of Heart Failure
Tilemann, L. M., Lee, A. A., Ishikawa, K., Agüero, J., Rapti, K., Santos‐Gallego, C. G., Kohlbrenner, E., Fish, K. M., Kho, C., & Hajjar, R. J. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006487 · Cited by 121
Fish Intake and the Risk of Incident Heart Failure: The Women's Health Initiative
Belin, R. J., Greenland, P., Martin, L. W., Oberman, A., Tinker, L., Robinson, J. G., Larson, J. C., Horn, L. V., & Lloyd‐Jones, D. M. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.110.960450 · Cited by 120
Identification of candidate long non-coding RNAs in response to myocardial infarction
Zangrando, J., Zhang, L., Vausort, M., Maskali, F., Marie, P., Wagner, D. R., & Devaux, Y. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-460 · Cited by 119
Urpí-Sardà, M., Casas, R. M., Chiva‐Blanch, G., Romero-Mamani, E.-S., Valderas-Martínez, P., Salas‐Salvadó, J., Covas, C., Toledo, E., Andrés‐Lacueva, C., Llorach, R., et al. (2012) · Journal of Nutrition · doi:10.3945/jn.111.148726 · Cited by 118
Ma, Z., Qi, J., Meng, S., Wen, B., & Zhang, J. (2013) · European Journal of Applied Physiology · doi:10.1007/s00421-013-2685-9 · Cited by 117
Lahey, R., Wang, X., Carley, A. N., & Lewandowski, E. D. (2014) · Circulation · doi:10.1161/circulationaha.114.011687 · Cited by 116
Connelly, K. A., Kelly, D. J., Zhang, Y., Prior, D., Advani, A., Cox, A. J., Thai, K., Krum, H., & Gilbert, R. E. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.765750 · Cited by 116
Targeting cardiac β-adrenergic signaling via GRK2 inhibition for heart failure therapy
Cannavò, A., Liccardo, D., & Koch, W. J. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00264 · Cited by 115
A MicroRNA Guide for Clinicians and Basic Scientists: Background and Experimental Techniques
Bernardo, B. C., Charchar, F. J., Lin, R. C. Y., & McMullen, J. R. (2011) · Heart Lung and Circulation · doi:10.1016/j.hlc.2011.11.002 · Cited by 115
Self-citationThe small-molecule BGP-15 protects against heart failure and atrial fibrillation in mice
Sapra, G., Tham, Y. K., Cemerlang, N., Matsumoto, A., Kiriazis, H., Bernardo, B. C., Henstridge, D. C., Ooi, J. Y. Y., Pretorius, L., Boey, E. J. H., et al. (2014) · Nature Communications · doi:10.1038/ncomms6705 · Cited by 113
Self-citationLiteráti-Nagy, B., Kulcsár, E., Literáti-Nagy, Z., Buday, B., Péterfai, E., Horváth, T., Tory, K., Kolonics, A., Fleming, A., Mandl, J., et al. (2009) · Hormone and Metabolic Research · doi:10.1055/s-0028-1128142 · Cited by 113
Gonzalez, G. E., Rhaleb, N., D’Ambrosio, M. A., Nakagawa, P., Liu, Y., Leung, P., Dai, X., Yang, X.-P., Peterson, E. L., & Carretero, O. A. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000358 · Cited by 112
Rizos, I. K. (2000) · American Heart Journal · doi:10.1067/mhj.2000.103917 · Cited by 111
Switching Metabolic Genes to Build a Better Heart
Taegtmeyer, H. (2002) · Circulation · doi:10.1161/01.cir.0000036760.42319.3f · Cited by 110
Paulin, R., Sutendra, G., Gurtu, V., Dromparis, P., Haromy, A., Provencher, S., Bonnet, S., & Michelakis, E. D. (2014) · Circulation Research · doi:10.1161/circresaha.115.303910 · Cited by 110
Fatty acid oxidation and mechanical performance of volume-overloaded rat hearts
Alaoui-Talibi, Z. E., Landormy, S., Loireau, A., & Moravec, J. (1992) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1992.262.4.h1068 · Cited by 109
Mitochondrial dysfunction and oxidative stress in CHF
Okonko, D. O., & Shah, A. M. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.189 · Cited by 109
Gray, M. O., Zhou, H.-Z., Schafhalter-Zoppoth, I., Zhu, P., Mochly‐Rosen, D., & Messing, R. O. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311459200 · Cited by 108
Isoform-selective HDAC inhibitors: Closing in on translational medicine for the heart
McKinsey, T. A. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.11.009 · Cited by 108
Higashikuni, Y., Tanaka, K., Kato, M., Nureki, O., Hirata, Y., Nagai, R., Komuro, I., & Sata, M. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000267 · Cited by 108
Ruppert, C., Deiss, K., Herrmann, S., Vidal, M., Oezkur, M., Gorski, A., Weidemann, F., Lohse, M. J., & Lorenz, K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221999110 · Cited by 107
Pathological hypertrophy amelioration by PRAS40-mediated inhibition of mTORC1
Völkers, M., Toko, H., Doroudgar, S., Din, S., Quijada, P. J., Joyo, A. Y., Ornelas, L., Joyo, E., Thuerauf, D. J., Konstandin, M. H., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301455110 · Cited by 106
Functional Consequences of Human Induced Pluripotent Stem Cell Therapy
Xiong, Q., Ye, L., Zhang, P., Lepley, M. A., Tian, J., Li, J., Zhang, L., Swingen, C., Vaughan, J. T., Kaufman, D. S., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000641 · Cited by 105
Effects of Tumor Necrosis Factor Gene Polymorphisms on Patients With Congestive Heart Failure
Kubota, T., McNamara, D. M., Wang, J. J., Trost, M. K., McTiernan, C. F., Mann, D. L., & Feldman, A. M. (1998) · Circulation · doi:10.1161/01.cir.97.25.2499 · Cited by 105
Henderson, K. K., Danzi, S. E., Paul, J. T., Leya, G. A., Klein, I. L., & Samarel, A. M. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.810747 · Cited by 105
Is AMPK the savior of the failing heart?
Kim, T. T., & Dyck, J. R. B. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.11.001 · Cited by 103
HDAC-dependent ventricular remodeling
Xie, M., & Hill, J. A. (2013) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2012.12.006 · Cited by 103
Aldosterone Receptor Antagonists: Effective but Often Forgotten
Maron, B. A., & Leopold, J. A. (2010) · Circulation · doi:10.1161/circulationaha.109.895235 · Cited by 103
Fan, G., Yuan, Q., Song, G., Wang, Y., Chen, G., Qian, J., Zhou, X., Lee, Y. J., Ashraf, M., & Kranias, E. G. (2006) · Circulation Research · doi:10.1161/01.res.0000251074.19348.af · Cited by 102
Postnatal Growth of the Heart and Its Blood Vessels
HUDLICKÁ, O., & Brown, M. D. (2008) · Journal of Vascular Research · doi:10.1159/000159155 · Cited by 101
Alterations in energy metabolism in cardiomyopathies
Taha, M., & Lopaschuk, G. D. (2007) · Annals of Medicine · doi:10.1080/07853890701618305 · Cited by 99
Ritchie, R. H., Love, J. E., Huynh, K., Bernardo, B. C., Henstridge, D. C., Kiriazis, H., Tham, Y. K., Sapra, G., Qin, C. X., Cemerlang, N., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2720-0 · Cited by 99
Self-citationNakamura, Y., Ueshima, H., Okamura, T., Kadowaki, T., Hayakawa, T., Kita, Y., Tamaki, S., & Okayama, A. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.12.016 · Cited by 98
Regitz‐Zagrosek, V., Shug, A. L., & Fleck, E. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)91383-h · Cited by 97
ORAL PROTEIN KINASE C β INHIBITION USING RUBOXISTAURIN
Aiello, L. P., Vignati, L., Sheetz, M. J., Zhi, X., Girach, A., Davis, M. D., Wolka, A. M., Shahri, N., & Milton, R. C. (2011) · Retina · doi:10.1097/iae.0b013e3182111669 · Cited by 96
Schönekess, B. O., Allard, M. F., & Lopaschuk, G. D. (1995) · Circulation Research · doi:10.1161/01.res.77.4.726 · Cited by 96
Hsp20 and Its Cardioprotection
Fan, G., CHU, G., & Kranias, E. G. (2005) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2005.05.004 · Cited by 94
Cardiac growth and angiogenesis coordinated by intertissue interactions
Walsh, K. X., & Shiojima, I. (2007) · Journal of Clinical Investigation · doi:10.1172/jci34126 · Cited by 93
Houser, S. R. (2014) · Circulation Research · doi:10.1161/circresaha.114.300569 · Cited by 93
Role of the renin-angiotensin system in cardiac hypertrophy
Yamazaki, T., Komuro, I., & Yazaki, Y. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00259-3 · Cited by 93
Sakamoto, M., Minamino, T., Toko, H., Kayama, Y., Zou, Y., Sano, M., Takaki, E., Aoyagi, T., Tojo, K., Tajima, N., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000252345.80198.97 · Cited by 92
Banquet, S., Gomez, É., Nicol, L., Edwards‐Lévy, F., Henry, J., Cao, R., Schapman, D., Dautréaux, B., Lallemand, F., Bauer, F., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.010264 · Cited by 92
Control of Cardiac Repolarization by Phosphoinositide 3-Kinase Signaling to Ion Channels
Ballou, L. M., Lin, R. Z., & Cohen, I. S. (2014) · Circulation Research · doi:10.1161/circresaha.116.303975 · Cited by 92
Laskowski, A., Woodman, O. L., CAO, A., Drummond, G. R., Marshall, T. P., Kaye, D. M., & Ritchie, R. H. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.07.006 · Cited by 91
Huusko, J., Lottonen‐Raikaslehto, L., Merentie, M., Gurzeler, E., Anisimov, A., Miyanohara, A., Alitalo, K. K., Tavi, P., & Ylä‐Herttuala, S. (2012) · Molecular Therapy · doi:10.1038/mt.2012.145 · Cited by 91
Myocardial triacylglycerol metabolism
Kienesberger, P. C., Pulinilkunnil, T., Nagendran, J., & Dyck, J. R. B. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.06.018 · Cited by 91
Ishikawa, K., Fish, K. M., Tilemann, L. M., Rapti, K., Agüero, J., Santos‐Gallego, C. G., Lee, A., Karakikes, I., Xie, C., Akar, F. G., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.127 · Cited by 91
Levitan, E. B., Wolk, A., & Mittleman, M. A. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp111 · Cited by 91
Anand, I. S., Chandrashekhan, Y., Giuli, F. D., Pasini, E., Mazzoletti, A., Confortini, R., & Ferrari, R. (1998) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1007721917561 · Cited by 89
Langenickel, T., & Dole, W. P. (2012) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2013.11.002 · Cited by 89
Klein, G. G., Schaefer, A., Hilfiker‐Kleiner, D., Oppermann, D., Shukla, P. C., Guba‐Quint, A., Podewski, E., Hilfiker, A., Schröder, F., Leitges, M., et al. (2005) · Circulation Research · doi:10.1161/01.res.0000161999.86198.1e · Cited by 88
Kee, H. J., Bae, E. H., Park, S., Lee, K. E., Suh, S. H., Kim, S. W., & Jeong, M. H. (2013) · Kidney & Blood Pressure Research · doi:10.1159/000350148 · Cited by 87
Giannetta, E., Feola, T., Gianfrilli, D., Pofi, R., Dall’Armi, V., Badagliacca, R., Barbagallo, F., Lenzi, A., & Isidori, A. M. (2014) · BMC Medicine · doi:10.1186/s12916-014-0185-3 · Cited by 87
Fischer, R., Dechend, R., Qadri, F., Markovic, M., Feldt, S., Herse, F., Park, J.-K., Gapelyuk, A., Schwarz, I., Zacharzowsky, U. B., et al. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.103143 · Cited by 86
G Protein–Coupled Receptor Kinase 2
Woodall, M. C., Ciccarelli, M., Woodall, B. P., et al. (2014) · Circulation Research · doi:10.1161/circresaha.114.300513 · Cited by 86
AMPK isoform expression in the normal and failing hearts
Kim, M., Shen, M., Ngoy, S., Karamanlidis, G., Liao, R., & Tian, R. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.01.016 · Cited by 83
The CRM1 Nuclear Export Receptor Controls Pathological Cardiac Gene Expression
Harrison, B. C., Roberts, C. R., Hood, D. B., Sweeney, M., Gould, J. M., Bush, E. W., & McKinsey, T. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10636-10649.2004 · Cited by 80
Järvinen, R., Knekt, P., Rissanen, H. A., & Reunanen, A. (2006) · British Journal Of Nutrition · doi:10.1079/bjn20051687 · Cited by 80
Xu, X. Y., Lu, Z., Fassett, J., Zhang, P., Hu, X., Liu, X., Kwak, D., Li, J., Zhu, G., Tao, Y., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02619 · Cited by 80
Bernardo, B. C., Nguyen, S. S., Winbanks, C. E., Gao, X., Boey, E. J. H., Tham, Y. K., Kiriazis, H., Ooi, J. Y. Y., Porrello, E. R., Igoor, S., et al. (2014) · The FASEB Journal · doi:10.1096/fj.14-253856 · Cited by 80
Self-citationPetretta, M., Condorelli, G., Spinelli, L., Scopacasa, F., Caterina, M. D., Leosco, D., Vicario, M. L. E., & Bonaduce, D. (2000) · American Heart Journal · doi:10.1067/mhj.2000.110935 · Cited by 79
Propionyl-L-carnitine: Biochemical significance and possible role in cardiac metabolism
Siliprandi, N., Lisa, F. D., & Menabò, R. (1991) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00128238 · Cited by 79
Increased susceptibility of hypertrophied hearts to ischemic injury
Friehs, I., & del Nido, P. J. (2003) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(02)04692-1 · Cited by 79
Bernardo, B., Gao, X.-M., Tham, Y., Kiriazis, H., Winbanks, C. E., Ooi, J., Boey, E. J. H., Obad, S., Kauppinen, S., Gregorevic, P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090337 · Cited by 79
Self-citationmicroRNA-34 family and treatment of cancers with mutant or wild-type p53 (Review)
Yang (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.970 · Cited by 79
The disconnect between phase II and phase III trials of drugs for heart failure
Vaduganathan, M., Greene, S. J., Ambrosy, A. P., Gheorghiade, M., & Butler, J. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.181 · Cited by 78
Zhu, Y., Zhu, Y. Z., Gohlke, P., Stauss, H. M., & Unger, T. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00465-7 · Cited by 78
ε Protein Kinase C in Pathological Myocardial Hypertrophy
Wu, G., Toyokawa, T., Hahn, H. H., & Dorn, G. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000380200 · Cited by 77
Fish, K. M., Ladage, D., Kawase, Y., Karakikes, I., Jeong, D., Ly, H. Q., Ishikawa, K., Hadri, L., Tilemann, L. M., Müller‐Ehmsen, J., et al. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.971325 · Cited by 77
Protein kinase Cα as a heart failure therapeutic target
Liu, Q., & Molkentin, J. D. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.004 · Cited by 76
Physiological activation of Akt by PHLPP1 deletion protects against pathological hypertrophy
Moc, C., Taylor, A. E., Chesini, G. P., Zambrano, C. M., Barlow, M. S., Zhang, X., Gustafsson, Å. B., & Purcell, N. H. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu243 · Cited by 76
Pyruvate dehydrogenase and the regulation of glucose oxidation in hypertrophied rat hearts
Lydell, C. P., Chan, A., Wambolt, R. B., Sambandam, N., Parsons, H., Bondy, G. P., RODRIGUES, B., Popov, K. M., Harris, R. A., Brownsey, R. W., et al. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00560-0 · Cited by 76
Jeffrey, F. M. H., Álvarez, L., Diczku, V., Sherry, A. D., & Malloy, C. R. (1995) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199503000-00018 · Cited by 74
Friehs, I., Margossian, R. E., Moran, A. M., Cao-Danh, H., Moses, M. A., & del Nido, P. J. (2005) · Basic Research in Cardiology · doi:10.1007/s00395-005-0581-0 · Cited by 74
Schwarzer, M., Osterholt, M., Lunkenbein, A., Schrepper, A., Amorim, P., & Doenst, T. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.274704 · Cited by 71
The therapeutic potential of miRNAs regulated in settings of physiological cardiac hypertrophy.
Ooi, J., Bernardo, B., & McMullen, J. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.13.196 · Cited by 71
Self-citationMitochondrial Reprogramming Induced by CaMKIIδ Mediates Hypertrophy Decompensation
Westenbrink, B. D., Ling, H., Divakaruni, A. S., Gray, C. B. B., Zambon, A. C., Dalton, N. D., Peterson, K. L., Gu, Y., Matkovich, S. J., Murphy, A. N., et al. (2015) · Circulation Research · doi:10.1161/circresaha.116.304682 · Cited by 70
p 38 MAPK in cardioprotection – are we there yet?
Martin, E. D., Bassi, R., & Marber, M. S. (2015) · British Journal of Pharmacology · doi:10.1111/bph.12901 · Cited by 69
Karch, R., Neumann, F., Ullrich, R., Neumüller, J., Podesser, B. K., Neumann, M., & Schreiner, W. (2005) · Cardiovascular Pathology · doi:10.1016/j.carpath.2005.03.003 · Cited by 68
Chien, K. R., Zangi, L., & Lui, K. O. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014035 · Cited by 68
Exercise training in chronic heart failure
Maeyer, C. D., Beckers, P. J., Vrints, C. J., & Conraads, V. M. (2013) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622313480382 · Cited by 67
Cardiac Intercellular Communication: Are Myocytes and Fibroblasts Fair-Weather Friends?
Martin, M. L., & Blaxall, B. C. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9404-5 · Cited by 67
Modesti, P. A., Vanni, S., Bertolozzi, I., Cecioni, I., Polidori, G., Paniccia, R., Bandinelli, B., Perna, A. M., Liguori, P., Boddi, M., et al. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.3.h976 · Cited by 67
AMPKα2 counteracts the development of cardiac hypertrophy induced by isoproterenol
Zarrinpashneh, E., Beauloye, C., Ginion, A., Pouleur, A., Havaux, X., Hue, L., Viollet, B., Vanoverschelde, J., & Bertrand, L. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.09.057 · Cited by 65
Cited by
Mechanisms of physiological and pathological cardiac hypertrophy
Nakamura, M., & Sadoshima, J. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0007-y · Cited by 1,658
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
Forrester, S. J., Booz, G. W., Sigmund, C. D., Coffman, T. M., Kawai, T., Rizzo, V., Scalia, R., & Eguchi, S. (2018) · Physiological Reviews · doi:10.1152/physrev.00038.2017 · Cited by 1,095
The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure
Cluntun, A. A., Badolia, R., Lettlova, S., Parnell, K. M., Shankar, T. S., Diakos, N. A., Olson, K. A., Taleb, I., Tatum, S. M., Berg, J. A., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.12.003 · Cited by 345
The role of CD36 in cardiovascular disease
Shu, H., Peng, Y., Hang, W., Nie, J., Zhou, N., & Wang, D. W. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvaa319 · Cited by 277
AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation
Gélinas, R., Mailleux, F., Dontaine, J., Bultot, L., Demeulder, B., Ginion, A., Daskalopoulos, E. P., Esfahani, H., Dubois-Deruy, E., Lauzier, B., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02795-4 · Cited by 253
Metadata
- Authors
- Tham, Y. K., Bernardo, B. C., Ooi, J. Y. Y., Weeks, K. L., & McMullen, J. R.
- Venue
- Archives of Toxicology
- Published
- 2015-02-24
- Volume
- 89
- Issue
- 9
- Pages
- 1401-1438
- ISSN
- 0340-5761 (ISSN-L)
- 1432-0738
- OpenAlex
- W1989434611
- Cited by
- 708
- References
- 464
- FWCI
- 24.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.